OraSure can't dump Abbott but it can have extra partners
This article was originally published in Clinica
Executive Summary
OraSure Technologies is not permitted to cancel its arrangement with Abbott Laboratories for the sale of its OraQuick rapid HIV-1 antibody tests, but it will in future be allowed to sign additional distribution partners. So said a US arbitrator, whose decision is final and may not be appealed by either of the former disputants.